JP2015500831A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500831A5
JP2015500831A5 JP2014545450A JP2014545450A JP2015500831A5 JP 2015500831 A5 JP2015500831 A5 JP 2015500831A5 JP 2014545450 A JP2014545450 A JP 2014545450A JP 2014545450 A JP2014545450 A JP 2014545450A JP 2015500831 A5 JP2015500831 A5 JP 2015500831A5
Authority
JP
Japan
Prior art keywords
pain
compound
pharmaceutical composition
phenylpropylamide
hydroxybenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014545450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500831A (ja
JP6411893B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2012/050512 external-priority patent/WO2013084238A1/en
Publication of JP2015500831A publication Critical patent/JP2015500831A/ja
Publication of JP2015500831A5 publication Critical patent/JP2015500831A5/ja
Application granted granted Critical
Publication of JP6411893B2 publication Critical patent/JP6411893B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2014545450A 2011-12-08 2012-12-06 (s)2−n(3−o−(プロパン2−オール)−1−プロピル−4−ヒドロキシベンゼン)−3−フェニルプロピルアミドの単離された立体異性体型 Active JP6411893B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161568219P 2011-12-08 2011-12-08
US61/568,219 2011-12-08
PCT/IL2012/050512 WO2013084238A1 (en) 2011-12-08 2012-12-06 Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017142137A Division JP2018021023A (ja) 2011-12-08 2017-07-21 (s)2−n(3−o−(プロパン2−オール)−1−プロピル−4−ヒドロキシベンゼン)−3−フェニルプロピルアミドの単離された立体異性体型

Publications (3)

Publication Number Publication Date
JP2015500831A JP2015500831A (ja) 2015-01-08
JP2015500831A5 true JP2015500831A5 (enExample) 2017-09-14
JP6411893B2 JP6411893B2 (ja) 2018-10-31

Family

ID=48573665

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014545450A Active JP6411893B2 (ja) 2011-12-08 2012-12-06 (s)2−n(3−o−(プロパン2−オール)−1−プロピル−4−ヒドロキシベンゼン)−3−フェニルプロピルアミドの単離された立体異性体型
JP2017142137A Pending JP2018021023A (ja) 2011-12-08 2017-07-21 (s)2−n(3−o−(プロパン2−オール)−1−プロピル−4−ヒドロキシベンゼン)−3−フェニルプロピルアミドの単離された立体異性体型

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017142137A Pending JP2018021023A (ja) 2011-12-08 2017-07-21 (s)2−n(3−o−(プロパン2−オール)−1−プロピル−4−ヒドロキシベンゼン)−3−フェニルプロピルアミドの単離された立体異性体型

Country Status (11)

Country Link
US (1) US9381173B2 (enExample)
EP (1) EP2788317B1 (enExample)
JP (2) JP6411893B2 (enExample)
CN (1) CN103998420B (enExample)
AU (1) AU2012348529B2 (enExample)
CA (1) CA2856665C (enExample)
DK (1) DK2788317T3 (enExample)
ES (1) ES2763946T3 (enExample)
HU (1) HUE048570T2 (enExample)
IN (1) IN2014MN00919A (enExample)
WO (1) WO2013084238A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173813A1 (en) * 2014-05-14 2015-11-19 Novaremed Ltd. Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes
KR102062268B1 (ko) 2018-05-18 2020-01-03 한국교통대학교 산학협력단 발광 특성 또는 전하 전달 특성이 우수한 아지드계 가교제
WO2020152226A1 (en) * 2019-01-23 2020-07-30 Novaremed Ltd. Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
EP3939578A1 (en) 2020-07-13 2022-01-19 Novaremed Ltd. Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1546088E (pt) 2002-10-03 2015-03-16 Novaremed Ltd Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
US20090197781A1 (en) 2008-01-31 2009-08-06 Hari Babu Sunkara Wellbore Fluids Comprising Poly(trimethylene ether) glycol Polymers
GB0804213D0 (en) * 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
PL2475361T3 (pl) 2009-09-09 2020-07-13 Novaremed Ltd. N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego
GB0916073D0 (en) 2009-09-14 2009-10-28 Cintec Int Ltd Improvements in and relating to building anchor systems

Similar Documents

Publication Publication Date Title
JP2013518107A5 (enExample)
JP2014500861A5 (enExample)
JP2010077141A5 (enExample)
JP2013032389A5 (enExample)
JP2011528713A5 (enExample)
JP2013542247A5 (enExample)
JP2011527299A5 (enExample)
JP2020097577A5 (enExample)
JP2013525444A5 (enExample)
JP2013508279A5 (enExample)
HRP20151000T1 (hr) Antivirusni spojevi
JP2009535352A5 (enExample)
JP2011518833A5 (enExample)
JP2017531038A5 (enExample)
JP2016530314A5 (enExample)
JP2017514910A5 (enExample)
EP4316591A3 (en) Oxysterols and methods of use thereof
JP2013537905A5 (enExample)
JP2012506872A5 (enExample)
JP2013542992A5 (enExample)
JP2007302689A5 (enExample)
JP2013502461A5 (enExample)
JP2014511366A5 (enExample)
JP2015500831A5 (enExample)
JP2013528659A5 (enExample)